listed · IPO · NSE SME · listed 29 May 2026

Bio Medica Laboratories Limited

Raised ₹52.43 Cr at ₹139 per share.

-20.0%

listing-day move

Price band

₹132 – ₹139

Issue price

₹139

Issue size

₹52.43 Cr

Return since listing

-16.69%

Company research

Source: Tijori Finance · third-party enrichment

About the company

Bio Medica Laboratories Ltd. manufactures pharmaceutical parenteral formulations, including liquid and dry powder injectables for human and veterinary use. The company operates GMP-compliant facilities and offers contract manufacturing services.

Financials (₹ crore)

Period	Revenue	PAT	Debt
Mar 2023	16.23 Cr	0.33 Cr	9.61 Cr
Mar 2024	15.25 Cr	2.5 Cr	10.49 Cr
Mar 2025	38.2 Cr	9.79 Cr	15.01 Cr

Revenue mix

Liquid injections 64.0%

Dry powder injection 35.1%

Others 0.9%

Peer comparison

Company	Mkt cap (Cr)	Revenue	PAT	P/E	P/B
BMLL	0	38.2 Cr	9.79 Cr	—	—
ZENOTECH	275	43.05 Cr	5.61 Cr	—	2.89
SHUKRAPHAR	1,235	32.59 Cr	9.58 Cr	56.01	13.75

Exchange filings

Fields captured from NSE and BSE

Issue information

Symbol: BMLL
Issue period: 2026-05-21 to 2026-05-25
Price range: Rs.132 to Rs.139
DRHP: https://nsearchives.nseindia.com/emerge/corporates/content/AD_IPO_6041_19112025191319.zip
Red Herring Prospectus: https://nsearchives.nseindia.com/emerge/corporates/content/BioMedicaLaboratoriesLimited_RHP.zip

Data sources: MONEYCONTROL , NSE , NSE . Data quality clean.